POPULARITY
71 episodes with glp1
14 episodes with glp1
8 episodes with glp1
6 episodes with glp1
5 episodes with glp1
2 episodes with glp1
2 episodes with glp1
5 episodes with glp1
4 episodes with glp1
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ___________________________________________________________________In this inspiring episode, we sit down with Jamie Selzler, a dedicated community member who has achieved a remarkable transformation, losing an incredible 340 pounds. Jamie shares his deeply personal journey, detailing his life in a larger body and how he successfully combined weight training with GLP-1 therapy to reach his goals. His story offers hope and practical insights for anyone navigating their own weight loss path.We also welcomed Dr. Koons, a board-certified obesity physician, who provides expert guidance on common challenges in weight loss. Dr. Koons tackles crucial topics like regain, plateaus (stalls), and metabolic function. He offers a compassionate and informed perspective on how individuals who have been impacted by diet culture can begin to heal their relationship with food and learn to effectively track their daily nutrition without guilt or shame.___________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez_____________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
What is in the This Week in Science Podcast? This Week: Funding State, mRNA HIV vaccine, Radioactive rhino horn, Wasting Source, Editing Diabetes, Roaches, Cockatoos, GLP1, Snails, Roach Bots, Political Sway, and Much More to Prompt You to Think Scientifically! Become a Patron! Check out the full unedited episode of our podcast on YouTube or […] The post 6 August, 2025 – Episode 1025 – Prompting You to Think Scientifically appeared first on This Week in Science - The Kickass Science Podcast.
Wegovy, (often referred to as Ozempic) was approved by the FDA in June 2021. Now that we have lived 4 years of a GLP frenzied hellscape, there must be new data on how well GLP1's work and how many lives they have saved. The numbers must be pretty impressive right? Hint: It's not impressive…not at all. Join me for part one of this deep dive into these (not so) new weight loss drugs where I share exactly how much weight people lose, if it improves their health (or worsens it), and all sorts of other nonsense that has been happening in the ensuing years after the press heralded Wegovy as a “game changer” that will “end” fatness. TW: for mentions of weight, mentions of children taking the drug and other general anti-fat ideas. Episode show notes: http://www.fiercefatty.com/199 Support me on Ko-Fi and get the Size Diversity Resource Guide: https://kofi.com/fiercefatty/tiers Ragen's 3 bullet points on GLPs: https://www.instagram.com/p/DKa5xdovYxa/?igsh=bHh1Nml0NW82bG83 https://www.cnn.com/2024/05/02/health/wegovy-weight-loss-drug-new-prescriptions Changes smell: https://www.instagram.com/p/DL0fFPER4QX/?img_index=7&igsh=Mmttb3Y4cG10dHUx The Community Ozempic Stole: As Influencers Lose Weight, Their Followers Feel "Abandoned": https://www.teenvogue.com/story/community-ozempic-stole-influencers-lose-weight Ozempic's Origin Story is Insane: https://youtu.be/9dMpY-ZALXc?si=lb6r-d08fEo9XVKB Dr Rachel Millner: Some thoughts about GLP-1s for intentional weight loss versus fat liberation as a value: https://www.instagram.com/p/DLzrBuuRqfW/?img_index=6&igsh=ODZpMmwyemlhdmxt Another post from Rachel she describes the side effects of GLPs when taken at a higher dose for weight loss and anorexia side effects/complications: https://www.instagram.com/p/DLOUiFKI8TB/ Retatrutide study: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Ragen's blog: https://weightandhealthcare.substack.com/p/weight-loss-drug-cage-match-part The Race Is On to Stop Ozempic Muscle Loss: Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs. Non paywall link: https://archive.ph/l25L9 https://www.nytimes.com/2024/02/08/well/live/ozempic-muscle-loss-exercise.html?utm_source=pocket_mylist The Race Is On to Stop Ozempic Muscle Loss: Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs. Non paywall link: https://archive.ph/l25L9 https://www.nytimes.com/2024/02/08/well/live/ozempic-muscle-loss-exercise.html?utm_source=pocket_mylist Changes smell: https://www.instagram.com/p/DL0fFPER4QX/?img_index=7&igsh=Mmttb3Y4cG10dHUx Hannah from Queenbeastsays, The Labour Government wants Britain to be "fat-free" by 2035: https://queenbeastsays.substack.com/p/the-labour-government-wants-britain?utm_source=app-post-stats-page&r=2qfqs8&utm_medium=ios&triedRedirect=true Contraception warning over weight-loss drugs after dozens of pregnancies: UK watchdog has had 40 reports relating to pregnancies in people using drugs such as Ozempic and Mounjaro https://www.theguardian.com/society/2025/jun/05/contraception-warning-over-weight-loss-drugs-after-dozens-of-pregnancies NPP Weight Loss Medications and Safety Planning: https://www.patreon.com/c/nalgonapositivitypride/home 7,000 potential claims already under active investigation Lawsuit Legal News+2Doyle APC Law Firm+2Darrow AI+2.
Dr. Robert Baron outlines major updates in type 2 diabetes care, emphasizing that blood sugar control alone does not significantly reduce cardiovascular risk, though it helps prevent microvascular complications. New guidelines now prioritize medications with proven cardiovascular and kidney benefits—GLP-1 receptor agonists and SGLT2 inhibitors—over traditional first-line therapy like metformin. Baron explains how these newer drugs not only lower blood sugar but also reduce the risk of heart attack, stroke, kidney disease, and heart failure, with added benefits such as weight loss. He also covers changes in screening, diagnosis, blood pressure goals, and individualized treatment strategies based on age, comorbidities, and patient preferences. [Health and Medicine] [Show ID: 40756]
My portfolio was way up yesterday - it's happened during 2 kinds of periods in the market. And we've got another day of HUGE earnings. Plus some other opportunities. Here are the links to all the sales: SAVE ON TRENDSPIDER - GET THE ANNUAL SUBSCRIPTION TO GET MY 4 HOUR ALGORITHM
Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare brain tumor.
Send us a textSo you've lost weight on a GLP-1 medication like Ozempic or Wegovy… but now you're thinking about stopping. What happens next?In this episode, we explore how to maintain your results after coming off GLP-1s. Studies show many people regain weight—but with the right strategies, you can keep the progress going.In this 15-minute episode, you'll learn how to:Rebuild hunger and fullness cues through mindful eatingProtect your metabolism with strength trainingStabilize blood sugar to reduce cravings and prevent fat regainThese aren't quick fixes—they're sustainable habits that will help you transition off medication with confidence and control.Your meds helped you start—now let your habits carry you forward.Listen in, choose one habit to focus on this week, and take your next step toward long-term success.Join us in our private Facebook group. Stop Chasing Wellness: Inner Circle Stop Chasing Wellness is an online wellness coaching company founded by two Holistic Health Coaches, Gina and Kristin. Be sure to check out all of our offerings including our book, Stop Chasing Wellness; Create It, and our growing catalog of Hormone Specific coaching courses. All of our courses and offerings are designed to help you feel and live your best life in a simplified way that works for you. You can find Stop Chasing Wellness on Facebook and Instagram
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ___________________________________________________________________In this inspiring episode, we sit down with Jamie Selzer, a dedicated community member who has achieved a remarkable transformation, losing an incredible 340 pounds. Jamie shares his deeply personal journey, detailing his life in a larger body and how he successfully combined weight training with GLP-1 therapy to reach his goals. His story offers hope and practical insights for anyone navigating their own weight loss path.We also welcomed Dr. Koons, a board-certified obesity physician, who provides expert guidance on common challenges in weight loss. Dr. Koons tackles crucial topics like regain, plateaus (stalls), and metabolic function. He offers a compassionate and informed perspective on how individuals who have been impacted by diet culture can begin to heal their relationship with food and learn to effectively track their daily nutrition without guilt or shame.___________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez_____________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Check out Marek Health at https://marekhealth.com/syatt and get 10% OFF your first order using code: SYATTIn this episode of The Jordan Syatt Mini-Podcast, I shoot the breeze and answer questions from listeners with my podcast producer, Tony, and we discuss:- Keeping the weight off after GLP1's- How to exercise when traveling for work- Incredible home gym equipment- The best exercises for improving posture- TRX only programs- How to stick to a program- Mixing Peloton with strength training- Rock climbing, Barre, Judo and Parkour- Flamin' Hots vs Takis and my favorite kinds of chips- And more...If you haven't heard this episode, you MUST listen to this episode about blood pressure: https://podcasts.apple.com/ca/podcast/how-to-improve-your-blood-pressure-my-story/id1348856817?i=1000558151464Use this discount code for Monkey Feet: https://bit.ly/4fDLXtRListen to my podcast with Dr. Spencer Nadolsky: https://podcasts.apple.com/us/podcast/famous-obesity-doctor-debunks-glp-1-weight-loss-shots/id1348856817?i=1000717566909Do you have any questions you want us to discuss on the podcast? Give Tony a follow and shoot him a DM on Instagram - @tone_reverie - https://www.instagram.com/tone_reverie/ I hope you enjoy this episode and, if you do, please leave a review on iTunes (huge thank you to everyone who has written one so far).Finally, if you've been thinking about joining The Inner Circle but haven't yet... we have hundreds of home and bodyweight workouts for you and you can get them all: https://www.sfinnercircle.com/
Happy Satiated Saturday! Something I've noticed in any body image healing exploration is how private body image concerns are. About 84% of women struggle with body image, yet something so prevalent is often kept hidden. I wonder what could change if how hard it is to live in a body could be openly discussed and supported, where conversations could look like: Person 1: How are you today?Person 2: I'm actually having a really hard time with my body image today.Person 1: Thanks for letting me know. I struggle a lot too. Is there anything you need in this experience today? I want to normalize body image struggles because I sense this might be the first step toward changing the conversations around living in a body. Rather than beginning with body acceptance or body love, sometimes you first just need to be with that, sometimes, because of a million different reasons, it is hard to be in your body and to like the way your body looks. In this week's Satiated Podcast episode, I chat with Anna Sweeney, Nutrition Therapist and Registered Dietitian, about: The complexities of body image healingThe impact of societal messaging and social mediaChallenging body image normsThe GLP-1 craze we're in right nowMedical stigmaFinding safety in the bodyYou can also read the transcript to this week's episode here: https://www.stephaniemara.com/blog/navigating-the-complexities-of-body-imageI hope you can join me Wednesday, August 27th at 5:00 pm ET for my upcoming Befriending Your Body Image Challenges with Somatic Eating® Practices Workshop. You can learn more and sign up HERE: https://satiated.mykajabi.com/offers/EkFBjX2Q/checkoutWith Compassion and Empathy, Stephanie Mara FoxKeep in touch with Anna: Website: www.wholeliferds.comInstagram: https://www.instagram.com/dietitiananna/Support the showKeep in touch with Stephanie Mara:Instagram: https://www.instagram.com/_stephaniemara/Facebook: https://www.facebook.com/stephaniemarafoxWebsite: https://www.stephaniemara.com/https://www.somaticeating.com/Linkedin: https://www.linkedin.com/in/stephmara/TikTok: https://www.tiktok.com/@stephaniemarafoxContact: support@stephaniemara.comSupport the show:Become a supporter: https://www.buzzsprout.com/809987/supportMy favorite water filter: https://www.pureeffectfilters.com/#a_aid=somaticeatingReceive 15% off my fave protein powder with code STEPHANIEMARA at checkout here: https://www.equipfoods.com/STEPHANIEMARAUse my Amazon Affiliate link when shopping on Amazon: https://amzn.to/448IyPl Special thanks to Bendsound for the music in this episode. ...
Literature Review 1) An exciting phase three trial with the CETP inhibitor Obicetrapib has shown serious promise for ASCVD and Alzheimer's Disease (AD). "In BROADWAY, a pre-specified AD sub-study was designed to assess plasma AD biomarkers in patients enrolled in the BROADWAY trial and evaluated the effects of longer duration of therapy (12 months) with a prespecified population of ApoE3/4 or 4/4 carriers. The sub-study included 1727 patients, including 367 ApoE4 carriers. The primary outcome measure was p-tau217 absolute and percent change over 12 months. Additional outcome measures included neurofilament light chain (“NFL”), glial fibrillary acidic protein (“GFAP”), p-tau181, and Aβ42/40 ratio absolute and percent change over 12 months. NewAmsterdam observed statistically significant lower absolute changes in p-tau217 compared to placebo over 12 months in both the full ITT population (p
#askthedoctor #podcast #wheyprotein Dr Michael Lange and Dr Susan Summerton host the longest running live medical talk show called "Ask the Dr" today August 2, 2025, form Salem Media. They discuss how to enhance the benefits of GLP1 weight loss drugs from a specific protein. Learn about the purest and most bio available protein that will help to stop sarcopenia that can be associated with GLP1receptor drugs. Sarcopenia is muscle wasting and strength loss. Fortifeye has developed 4 products that can be used in combination with GLP1 drugs to help stop the unwanted muscle loss. Fortifeye Super Protein, Fortifeye Grass Fed Whey Isolate, Fortifeye Super Vegan Protein and Fortifeye Fit Pro. Learn about these at www.fortifeye.com Most Americans are not consuming enough protein and both doctors go into more details on this subject. Dr Lange stated he started his Dr Langes Boot Camp for one month to lose 25 lbs. He started yesterday. Both docotrs discus Marine collagen tripeptides and Dr Lange mentioned Morikol and Fortifeye Rejuvenate Marine Collagen tripeptide. The doctors discussed how you must be careful when purchasing vitamins and learn to read labels making sure the supplements are not filled with toxic ingredients and very low levels of nutrients. Fortifeye Vitamin company is based on their motto Right Ingredients, Right Science, Right for You. A discussion on how to protect the retina and macula after cataract surgery with specific nutritional supplements. Dr Lange recommends everyone taking Fortifeye Focus after cataract surgery to increase macula pigment density and thus protect the macula against possible blue light damage. Both doctors see patients at the Lange Eye Institute in The Villages Fla. call 352 753-4014 for an appointment. Fortifeye Vitamins number is 866 503-9746 #askthedoctor #podcast #wheyprotein #dryeyerelief #wheyproteinisolate #askthedr #drmichaellange #motivation #wellnesssaturday #drlangewellness #antiagingtips #antiagingsecrets #grassfedwhey #grassfedprotein #newzealandwhey #proteinpowder #veganprotein #marinecollagen #marinecollagentripeptide #longevity #longevityshow #longestrunningmedicaltalkshow #optometry #optometrylife #optometristSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure. When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app. If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death. Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said. Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin. https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom. CEO Kevin Sayer will step down & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score. However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes. “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.” https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/ XX Formal recognition for the specialty of Diabetology. Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone. The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen. About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday. Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment. What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism. While the study didn't identify which artificial sweeteners were at play, Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture. Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk. https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders. The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs. Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan. That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge. The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings. That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/ XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html
Send us a textDr. Meghan Garcia-Webb has been helping CEOs, attorneys, physicians, and consultants look and feel better for years, and she is attuned to the concerns of high achieving individuals, as well as the specific mindset traps that befall even the most organized personality.She is board-certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, bringing her patients the latest evidence-based therapies. She is also certified as a life coach through The Life Coach School, the premier choice for physician coaches. Through this unique combination of skills, she has pioneered an innovative hybrid model of customized care, creating lasting results for patients with ease.Dr. Garcia-Webb earned her B.S. at Tufts University, and her M.D. from the University of Vermont Medical School. She completed her residency in internal medicine at the University of Massachusetts. In addition to her clinical work, she produces a weekly YouTube series, Weight Medicine with Dr. Meghan.Dr. Garcia-Webb has been featured in publications such as Time, GQ, Food & Wine, The NY Post, Men's Health, Newsweek, Prevention, and Parade magazine.Find Dr. Meghan Garcia-Webb at-YT- @Weight Medicine with Dr. Meghan MDhttps://weightmedicinemd.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!
THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 The Speaker's Stump Speech is brought to you by https://www.hansenstree.com/ and is is about the climate change timeline of failed predictions 14:06 SEG 2 DR. RANDY TOBLER, Host of The Randy Tobler Show on NewsTalkSTL Saturday mornings from 6-9 and co-host of Wake Up Missouri weekdays on 93.9 The Eagle in Columbia | TOPIC: Moving production to USA | NFL shooter in NYC suffering from CTE? | Effects of GLP1’shttps://x.com/RandyToblerMD https://bodyofhealth.com/ 30:47 SEG 3 Chicago Cubs Hall of Famer Ryne Sandberg dies at 65 https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.
THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 The Speaker's Stump Speech is brought to you by https://www.hansenstree.com/ and is is about the climate change timeline of failed predictions 14:06 SEG 2 DR. RANDY TOBLER, Host of The Randy Tobler Show on NewsTalkSTL Saturday mornings from 6-9 and co-host of Wake Up Missouri weekdays on 93.9 The Eagle in Columbia | TOPIC: Moving production to USA | NFL shooter in NYC suffering from CTE? | Effects of GLP1’shttps://x.com/RandyToblerMD https://bodyofhealth.com/ 30:47 SEG 3 Chicago Cubs Hall of Famer Ryne Sandberg dies at 65 https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Continuing our vital conversation from GLP-1s & Men's Health: Jhon Henri's Weight Loss Story P1, we welcome Dr. Catherine Toomer an expert on weight management, who offers her insights on weight, health, and metabolic well-being. Building on Jhon Henri's powerful story and how GLP1s changed his life, Dr. Toomer unpacks the complexities of obesity as a disease, the limitations of BMI, and why the focus should shift from simple weight loss to metabolic correction.Discover why societal views on weight, particularly for men, contribute to healthcare disparities, and how GLP-1 medications work beyond "food noise" to address underlying metabolic issues. Dr. Toomer also sheds light on the often-misunderstood connection between rapid weight loss and gallstones, and candidly discusses the physiological changes women experience during perimenopause and menopause, including the role of estrogen decline in weight gain.This episode is a must-listen for anyone seeking a deeper understanding of chronic weight management, the importance of advocating for your health, and the journey toward holistic well-being.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez____________________________Send us Fan Mail!Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Depuis quelques années sont apparus sur le marché les analogues du GLP1, des injections qui court-circuitent le cerveau et réduisent les envies de nourriture en augmentant le sentiment de satiété. Une révolution dans la prise en charge de l'obésité qui peut induire une perte de poids égale ou supérieure à la chirurgie bariatrique. Les médecins spécialisés dans l'obésité croulent sous les demandes et mettent en place des séances d'information afin de prévenir : ces médicaments ne sont pas une baguette magique et ne doivent pas être prescrits sans prise en charge multidisciplinaire. Reportages Géraldine Genetti Réalisation Jean-Daniel Mottet Production Laurence Difélix
The VENTOUX study of endurance athletes, the 10,000 step myth was not busted, rate vs rhythm control for AF, and GLP1 drugs and observational studies are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Endurance Athletes and Arrhythmia (again) VENTOUX trial https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.125.018470 II Daily Step Count and Health — no myths were busted. Lancet Public Health: https://doi.org/10.1016/S2468-2667(25)00164-1 III Rate vs Rhythm Control of AF Medscape: Everyone Deserves a Shot at the American Dream: Sinus Rhythm https://www.medscape.com/viewarticle/everyone-deserves-shot-american-dream-sinus-rhythm-2025a1000jle This Week in Cardiology, July 11, 2025 https://www.medscape.com/viewarticle/1002704 AFFIRM trial https://www.nejm.org/doi/full/10.1056/NEJMoa021328 AFFIRM substudy https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/486560 IV GLP-1 Drugs and Observational Studies Neurodegeneration and Stroke After Semaglutide and Tirzepatide https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836412 SUSTAIN-6 https://www.nejm.org/doi/full/10.1056/NEJMoa1607141 SELECT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net
Best known for weight loss and blood sugar control, GLP-1 drugs might also reduce the stubborn inflammation behind hidradenitis suppurativa (HS). Early research shows they may impact key inflammatory pathways—and even improve HS symptoms (including painful skin boils) without major weight loss.But big questions remain: How do they interact with current HS treatments? Who can prescribe them? What happens if you stop?Dermatologist and HS expert Dr. Steven Daveluy returns to unpack the science, share insights, and explore what this could mean for the future of HS care. Don't miss it!⭐️Mentioned in This Episode:- See all the references
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________In this candid and powerful episode of The Plus SideZ Podcast, we sit down with Jhon Henry, a GLP-1 advocate who shares his weight loss journey, the impact of food noise, and what it means to be a man navigating obesity, diabetes risk, and healthcare bias.Jhon opens up about growing up in a bigger body, feeling dismissed by doctors, discovering GLP-1 medications, and finding purpose in helping other men—especially Black men—advocate for their health. From overcoming stigma to building a care team that listens, his story is one of vulnerability, grit, and community.We also dive into why BMI is broken, the mental toll of lifelong weight loss pressure, and how GLP-1 medications are transforming lives beyond the scale. Plus, Kim and Kat talk about shifting the conversation toward hormone health, advocacy, and what comes after weight loss.Whether you're on a GLP-1, love someone who is, or just want to hear real talk about health and healing—this episode is for you.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Top Two: LIliana. North Star Deli, Bootlegger & Loring Park Art Festival and GLP1 drugs are changing how restaurants market, interesting update from Stephanie H. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
TSA has quietly changed the checking the shoes policy and is thinking about changing the liquid rule. Researchers believe that GLP1 medications could help prevent dementia. President Trump claims that he has convinced Coca Cola to use cane sugar in their beverages. A Michigan woman is suing Monster Energy because she claims she found a mouse in her energy drink. The doll handler for Annabelle the haunted doll is dead and the doll is currently missing.See omnystudio.com/listener for privacy information.
Dr Jairo Noreña is an Endocrinology Fellow at Stanford University.After training as a physician in his native Colombia, Jairo moved to the States to continue dedicating his life to medicine. With a triple specialisation in Internal Medicine, Endocrinology, and Obesity Medicine as well as long-standing fellowships at prestigious universities including Harvard, Columbia and of course Stanford, to say Jairo has a wealth of expertise in endocrinology and diabetes would be an understatement. In this fascinating episode we discuss how GLP-1s can help people living with type 1 diabetes, the rise of 'double diabetes' when a person has both type 1 and type 2 diabetes, and get back to basics with a helpful exploration of what the endocrine system actually is!CONNECT WITH DR NOREÑAFollow Jairo on Instagram.Take a look at his website.Subscribe to Jairo's YouTube channel.JOIN THE TYPE 1 ON 1 COMMUNITY Come and say hi @studiotype1on1 on Instagram.Visit the Type 1 on 1 website.Subscribe to the Type 1 on 1 newsletter.DISCLAIMER Nothing you hear on Type 1 on 1 should be taken as medical advice. Please consult your healthcare team before making any changes to your diabetes or health management.SPONSOR MESSAGE This episode of Type 1 on 1 is sponsored by Dexcom. Using Dexcom CGM has given me so much confidence to make informed diabetes treatment decisions in the moment.You can choose to wear it on your arm or your abdomen, and all Dexcom CGMs have the share and follow feature even when connected to an insulin pump, so family and friends can see your glucose levels and get alerts, giving that extra bit of support when needed.Head to Dexcom.com to request a free Dexcom ONE+ sample.Always read the user manual for important product aspects and limitations. Talk to your doctor for diabetes management terms and conditions and terms of use.
In this episode of Good Day Health, Doug Stephan welcomes back Elizabeth Miller to talk about one of the most trusted natural weight loss supplements on the market — Calotren. Unlike trendy quick-fix programs or stimulant-based diet pills, Calotren supports sustainable weight loss and muscle health while you sleep. Taken before bed, it works with your body's natural healing cycle to:Improve sleep qualityReduce joint painSupport lean muscle retentionBoost metabolism and energyGently tone and tighten skinWith an 86% success rate in the first 90 days, users see better sleep by month 1, and steady inch and weight loss by month 2 and beyond — all without the rebound weight gain so common with other methods. Doug and Elizabeth also discuss the rise of prescription weight-loss shots and how Calotren is safe to use alongside them — in fact, it may be essential for helping your body retain lean muscle and avoid energy crashes or sagging skin. Plus: To celebrate their website relaunch at TopLoss.com, shoppers get free gifts with every order, and free shipping when you use promo code DOUG at checkout. Visit TopLoss.com, click on “Shop Radio Sale,” and start your Calotren journey today. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks
It's the latest health trend to go global, largely thanks to social media. But is off-label use of weight loss drugs actually effective or advisible? Metabolics expert Ali Hashemi is on hand with the answers. Meanwhile, as a post about the realities of dating in Dubai sparks conversation on Facebook, we talk break-ups, get-togethers and everything in between with psychologist Charlotte Spurway. And Conde Nast Traveller's Selena Denman joins Helen to talk travel - and the rise of the last minute long haul break...See omnystudio.com/listener for privacy information.
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________We're bringing back one of our most powerful and downloaded episodes from Season 1 — "Fat and Lazy" with Dr. Rosen — because we've got so many new subscribers who need to hear this.In this episode, Kim opens up about her own obesity story — the stigma, the shame, the survival with GLP-1. Dr. Rosen, a leading expert in weight loss surgery, breaks down how GLP-1 medications were reverse-engineered from bariatric surgery research and what that means for treatment today.Together, we dismantle the toxic myth of “fat and lazy” and make it crystal clear: obesity is not a character flaw — it's a chronic disease.If you're new to the pod or just need a reminder that you're not alone and it's not your fault, this one's for you.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Microdosing GLP1s has become a buzzword across social media, but most of what's being promoted isn't accurate or aligned with what I've taught. In this episode, I'm setting the record straight. From telemedicine companies marketing standard starting doses as “microdosing,” to influencers pushing products under the guise of inflammation support, it's time we talk about what's really going on. I'll break down the origins of this conversation, what the concept of microdosing was actually intended for, and why it's NOT an effective weight loss strategy. If you've seen my name mentioned in this space, or if you're confused by the mixed messaging online, this episode is for you. Topics Discussed: → What's the difference between microdosing and standard GLP1s? → Microdosing GLP1s vs standard dosing: how do they compare? → How is microdosing GLP1s different from regular dosing? → Microdosing or standard GLP1s – which one are you actually doing? → Are you really microdosing GLP1s, or just using the standard dose? Sponsored By: → BIOptimizers| Go to bioptimizers.com/tyna and use promo code DRTYNA to order Masszymes now and get 10% off any order → LVLUP | Head over to LVLUPHealth.com and use code DRTYNA at checkout to get 20% off your order sitewide. → Manukora | Head to manukora.com/DRTYNA to save up to 31% & $25 worth of free gifts in Starter Kit, which comes with an MGO 850+ Manuka Honey jar. →Timeline | Head to timeline.com/DRTYNA and get 20% off with code DRTYNA → Resilience | Go to https://store.drtyna.com/products/resilience and use code Resilience10 for 10% off the entire store On This Episode We Cover: → 00:00:00 - Introduction → 00:07:29 - The microdose strategy → 00:11:03 - Off-label use & chronic illness risks → 00:14:48 - Weight loss → 00:16:47 - Key benefits of GLP1s → 00:23:17 - NYT Interview → 00:24:25 - Price splitting & influencer scams → 00:26:30 - GLP1 clickbait → 00:29:51 - Inflammation & aging → 00:36:31 - GLP1 Done Right University → 00:38:31 - Why microdosing is NOT effective → 00:40:13 - Titration → 00:44:09 - GLP1 treatment explained → 00:47:49 - Understanding different peptide types → 00:53:39 - Overview Show Links: → GLP-1s Done Right University → Strength Corner → Metabolic Revamp Toolkit Ozempic Uncovered Podcast Series: → EP 106: Ozempic Done Right Part 1 | Solo Episode → EP 107: Ozempic Done Right Part 2 | Solo Episode → EP. 109: Ozempic Done Right Part 3 | Solo Episode → Ep. 116: Berberine: NOT Nature's Ozempic | Quick & Dirty → EP. 118: My GLP-1 Experience | Quick & Dirty → EP. 129: Ozempic Done Right Part 4: Sustained Weight Loss | Solo Episode → EP. 132: Ozempic Done Right Part 5: Osteoarthritis + GLP1 Agonists | Solo Episode → EP. 136: Ozempic Does NOT Cause Muscle Loss | Solo Episode Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
Ask Me A Question For Next Week's Episode!Included in this episode: A much needed updated podcast about peptides and their new approvals for different applications. GLP1s are incredible tools for weight loss. Talk to your doctor. Authentic application of a GLP1 as a tool for weight loss. Nutrition management and movement will always be required. Nothing will replace a calorie deficit but there are lots of ways to get you there. Don't be ashamed. Don't compare your journey with someone else's. Don't put it off. Make a change today.
Elizabeth welcomes Dr. Tyna Moore for a straight-shooting conversation on one of the most talked-about topics in wellness right now: GLP-1s. A naturopathic physician, podcast host, and expert in regenerative medicine, Dr. Moore has been at the forefront of the metabolic health conversation for years, and she's not afraid to challenge the hype.In their chat, Elizabeth and Dr. Moore get into what GLP-1s actually do in the body beyond weight loss, from regulating blood sugar to calming inflammation and supporting brain health. They unpack the potential of microdosing peptides as a tool, not a quick fix, and talk through the lifestyle habits that make or break your results. They also explore the limitations and risks of using GLP-1s without context, and the role of strength training, sleep, and upping your protein intake in hormone health. Episodes Here Say Hi To Elizabeth and Purely Elizabeth: Website | InstagramDr. Tyna Moore: Website | The Doctor Tyna Show
Tyna Moore, ND, DC, has nearly three decades experience in the medical world. She made her mark as a leading expert in holistic regenerative medicine and resilient health. Traditionally and alternatively trained in both science and medicine, Dr. Moore brings a unique perspective to those wishing to build a more robust foundation in their health and well-being. She is the host of The Dr. Tyna Show Podcast, #1 best-selling author, and international speaker. She helps others improve their resilience and metabolic health through multiple online offerings.https://www.drtyna.com/https://www.instagram.com/drtynahttps://youtube.com/@drtyna_______________________________________________________________________________________Come check out the Buff Muff Community!www.buffmuff.comThank you so much for listening! I use fitness and movement to help women prevent and overcome pelvic floor challenges like incontinence and organ prolapse. There is help for women in all life stages! Every Woman Needs A Vagina Coach! Please make sure to LEAVE A REVIEW and SUBSCRIBE to the show for the best fitness and wellness advice south of your belly button. *******************I recommend checking out my comprehensive pelvic health education and fitness programs on my Buff Muff AppYou can also join my next 28 Day Buff Muff Challenge https://www.vaginacoach.com/buffmuffIf you are feeling social you can connect with me… On Facebook https://www.facebook.com/VagCoachOn Instagram https://www.instagram.com/vaginacoach/On Twitter https://twitter.com/VaginaCoachOn The Web www.vaginacoach.comGet your Feel Amazing Vaginal Moisturizer Here
Resources for the Community___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials United States Patent & Trademark Office Website and Email https://www.uspto.gov/usptoinfo@uspto.govi-MAK Websitehttps://www.i-mak.org/i-MAK Briefs & Reports https://www.i-mak.org/resource-type/briefs/______________________________________________________________________Tahir Amin, founder of I-MAK, joins us to break down why GLP-1 meds like Ozempic and Mounjaro stay so pricey. We dig into evergreening, patent thickets, and how pharma companies use legal loopholes to delay generics and extend monopolies.We also explore why some companies spend more on stock buybacks than drug innovation—and what that means for access. If you've felt exploited by the system, you're not alone. But there's hope. Learn about the policy changes ahead and how you can take action to fight for affordable meds.Tahir Amin bio:Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address the systemic inequities in how medicines are developed and distributed. He has over 30 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. His work focuses on changing the structural power dynamics that allow health and economic inequities to persist by challenging and re-shaping IP laws and the related global political economy to better serve the public interest. He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and has served as legal advisor/consultant to many international groups, including the European Patent Office and World Health Organization, as well as testifying before the U.S. Congress on intellectual property and unsustainable drug prices.Special Guest Co-Host, Amanda Bonello from GLP-1 Collective https://glp1collective.org/ _______________________________Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
I am honored to reconnect with Dr. Tracy Gapin today. He is a board-certified urologist and men's health expert. The current state of metabolic health in the United States and most Westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. I wanted to speak with a clinician who actively uses this medication. Dr. Gapin and I discuss what this drug class represents. (These are synthetic peptides.) We speak about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. We get into current research, side effects, who should not take these medications, the mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety. We discuss changes in the brain regarding leptin and how these drugs work. We also talk about weight loss resistance, and I answer questions from listeners. From my perspective, it all comes back to basics. I believe that if we are to prescribe these medications, we must help our patients understand how lifestyle impacts weight-loss resistance and metabolic health. I loved that Dr. Tracy spent some time talking about the specific ways he works with his patients, even before prescribing medications. He also explains how important he feels this drug has been for his patients. I approached today's conversation with an open mind, and I hope you will do the same. IN THIS EPISODE YOU WILL LEARN: GLP1 agonists, and how they help Dr. Tracy motivate his patients to lose weight What are GLP1 agonists, and how do they work? Physical benefits of GLP1 agonists Who is Semaglutide not appropriate for? Common side-effects of GLP1 agonists How those who fail to implement lifestyle changes when they stop using Semaglutide may regain all the weight they lost Hydration while using Semaglutide Protein intake when taking Semaglutide How to follow the metrics that matter Factors that could hinder successful weight loss What Dr. Tracy does to ensure his patients do not regain the weight they lost after they stop using Semaglutide Listener questions: Why is a diabetic drug being used for non-diabetics? Does this drug target muscle versus fat in terms of weight loss? For how long do most patients take it? Are there unique characteristics in perimenopausal and menopausal women that must be accounted for differently? Bio: Dr. Tracy Gapin is a board-certified urologist and a world-renowned expert in men's health and performance, as well as the founder of the Gapin Institute, the global leader in High-Performance Health. He has over 20 years of experience focused on men's health optimization, human performance, and longevity, providing executives & entrepreneurs a personalized path to fulfill their highest potential. He's been featured in Entrepreneur, Dave Asprey's Biohacking Conference, and as a TEDx speaker. Connect with Cynthia Thurlow Follow on Twitter, Instagram & LinkedIn Check out Cynthia's website Connect with Tracy Gapin On his website Gapin Institute
Send us a message with this link, we would love to hear from you. Standard message rates may apply.On this episode discuss the side effects of GLP-1 medications like Ozempic and Wegovy, Zepbound, and Mounjaro offering practical strategies to manage these effects while still benefiting from the medications.• GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) help manage type 2 diabetes, obesity, and can reduce cardiovascular risk• Most common side effects are gastrointestinal: nausea, vomiting, diarrhea, bloating, and constipation• "Sulfur burps" are a frequently reported side effect that some manage with Pepto-Bismol• Start with low doses and increase slowly to minimize side effects• Eat smaller portions, avoid greasy/spicy foods, and practice mindful eating to reduce GI symptoms• Stay hydrated and increase fiber intake to prevent constipation• Gallbladder problems and pancreatitis risk may increase with rapid weight loss• Some evidence suggests potential vision changes requiring regular eye check-ups• Medications like insulin or blood pressure drugs may need adjustment when on GLP-1s• Most side effects improve with time as your body adjusts to the medicationSend us an email at yourcheckuppod@gmail.com or visit our Instagram or website to stay updated with weekly episodes released every Monday.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski
What do Zumba and Greek dancing have to do with bone density? Why should you shave first and soak later? And who gets to decide whether you can have a hysterectomy for health reasons if you haven’t had kids yet? In this episode, Endocrinologist Dr Sonia Davison from Jean Hailes for Women’s Health talks about whether diet and exercise can prevent dementia and what waist circumference has to do with healthy ageing. She also discusses how stomping, sleeping and strength training should all be part of the puzzle as you get older. We also talk about intermittent fasting and how cups of tea with your girlfriends could be just what the doctor ordered. And, is it possible to delay your ‘hormone window of chaos’? THE END BITS For more information on bone density Dr Sonia Davison recommends: Healthy Bones Australia For more information on fibroids Dr Mariam recommends: ask4ufe Sign up to the Well Newsletter to receive your weekly dose of trusted health expertise without the medical jargon. Ask a question of our experts or share your story, feedback, or dilemma - you can send it anonymously here, email here or leave us a voice note here. Ask The Doc: Ask us a question in The Waiting Room. Follow us on Instagram and Tiktok. All your health information is in the Well Hub. Support independent women’s media by becoming a Mamamia subscriberCREDITS Hosts: Claire Murphy and Dr MariamGuest: Dr Sonia DavisonSenior Producers: Claire Murphy and Sasha TannockAudio Producer: Scott Stronach Mamamia studios are styled with furniture from Fenton and Fenton. Visit fentonandfenton.com.au Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures.Information discussed in Well. is for education purposes only and is not intended to provide professional medical advice. Listeners should seek their own medical advice, specific to their circumstances, from their treating doctor or health care professional.See omnystudio.com/listener for privacy information.
“I was a 10-year-old 122lb fourth grader, publicly ridiculed and humiliated when my class witnessed the number on the scale. My weight wasn't just on my body—it was on my confidence, my relationships, my future. But the moment I stopped trying to be 'less' and started choosing wholeness over perfection, everything changed.”In this episode, we sit down with a powerful woman who turned her deepest insecurities into her greatest mission. Once overwhelmed by body shame and self-doubt, she's now a thriving Registered Nurse helping others reclaim their health—not just physically, but emotionally and spiritually.You don't want to miss this raw, redemptive, and real conversation about healing, self-worth, and what it truly means to thrive.You are ENOUGH. You are WORTHY.Enjoy-Wellness.comAliceHarveyrn@gmail.com
In this episode, we talk about one of the most popular medications on the market right now - GLP1 receptor agonists - with Dr. Greg Gatchell, a physician boarded in Family Medicine, Lifestyle Medicine, and Obesity as well as a certified health coach. We unpack the real science of weight gain, hormones, and the role of hormones like insulin and GLP-1. We break down how GLP-1 medications work, who they're best suited for, and the common myths surrounding these drugs. Together, we explore why weight loss is about more than willpower alone, the importance of lifestyle support even when using medications, and how to make informed choices about long-term obesity management. Whether you're considering a GLP-1 prescription, supporting a loved one, or simply curious about how modern medicine tackles obesity, this episode will give you practical, compassionate insights you can use today!Connect with Dr. Greg Gatchell, DO:LinkedInConnect with Dr. Jonar, MD: Book Your Free Health Coaching Consult with Dr. Jonar4 Truth Health CoachingInstagramFacebookLinkedin ThreadsDr. Jonar Website HOW CAN I SUPPORT THIS PODCAST?Download, Listen, Subscribe, Rate & Review: Glass Half Healthy on Apple Podcast Glass Half Healthy on SpotifyTell Your Family & Friends! And Share Online!Thanks to Dan Olfato for production help and to StockSounds for the music. And to YOU! Thank you for listening!Disclaimer:This podcast is intended for educational purposes only and isn't medical advice so please talk to your primary physician for that. In addition, the views and opinions expressed by me are my own and not that of my former, current or future employer. This also applies to my guests. Finally, we do our best to make every effort to relay correct information, but don't guarantee its accuracy. Thank you for listening.
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55______________________________________________________________________Dr. David Kessler, former FDA Commissioner and author of Diet, Drugs, and Dopamine, joins us to break down the science behind food addiction, obesity, and GLP-1 medications like Ozempic and Zepbound.He doesn't just study this—he lives it. Dr. Kessler has obesity, takes GLP-1s, and knows firsthand what it's like to battle food noise and weight stigma.In this episode, we discuss:What makes ultra-processed food addictiveHow GLP-1s affect the brain and reduce cravingsWhether some people can stop taking GLP-1sHis personal experience starting, stopping, and restartingWhy weight regain happens and what the body is really fightingHis bold policy ideas to regulate Big Food like Big TobaccoDr. Kessler helped bring HIV drugs to market faster, led Operation Warp Speed, and took on the tobacco industry. Now, he's focused on the next public health crisis: food addiction and obesity.Subscribe to The Plus SideZ Podcast for more expert conversations on GLP-1s, weight, and wellness.Specialist and Community Guest Dr. David KesslerBIO: David. A. Kessler, MD, served as chief science officer of the WhiteHouse COVID-19 Response Team under President Joe Biden and previouslyserved as commissioner of the US Food and Drug Administration underPresidents George H.W. Bush and Bill Clinton. He is the author of the_New York Times_ bestsellers _The End of Overeating_ and_ Capture_ andtwo other books:_ Fast Carbs, Slow Carbs_ and _A Question of Intent_.Dr. Kessler is a pediatrician and has been the dean of the medicalschools at Yale and the University of California, San Francisco. He is agraduate of Amherst College, the University of Chicago Law School, andHarvard Medical School.Social Media:https://x.com/DavidAKesslerMDLink to Book:https://www.audible.com/pd/B0D5KS9P4D?source_code=ASSORAP0511160006&share_location=pdpSpecial community guest Mike on a Health Mission Social MedSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Ozempic is one of the most import new medications in a generation. The scientist who created it is a self-described "nerd," who grew up on a farm in Denmark and has no interest in the limelight. Lotte Knudsen started her career working on laundry detergent enzymes, but eventually joined a team at the Danish pharmaceutical company Novo Nordisk that was tasked with looking for new treatments for diabetes. She was convinced that a recently discovered human hormone called GLP-1 could be made into a powerful medication, not only for Type 2 diabetes, but also for weight loss. It took 20 years of hard work and persistence for her and her team to figure it out, but their creation now shows promise as a worthy foe of heart disease, kidney disease, Parkinson's, alcoholism & Alzheimer's as well. In this episode Lotte Knudsen tells her story, and we hear from two of the other scientists who made critical contributions to this revolution in medicine: Mads Thomsen and Daniel Drucker.
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: loads of news from American Diabetes Association Scientific Sessions, GLP1 for T1D, Tech updates, diabetes in space, and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Top story – looking back at The American Diabetes Association Scientific Sessions conference. I won't recap everything here – but I'll link up to a few more comprehensive article. Here's just a taste! XX A single infusion of a new stem cell-based treatment helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made by Vertex Pharmaceuticals. It's an infusion of lab-grown islet cells. A year after getting the therapy, 10 patients no longer needed insulin shots. The other two were able to reduce how much insulin they needed. The treatment requires patients to take immunosuppressive drugs, which may raise the risk of infections or cancer in the long run, experts said. https://www.usnews.com/news/health-news/articles/2025-06-24/stem-cell-treatment-may-free-some-with-type-1-diabetes-from-insulin XX New study shows inhaled insulin is safe and effective for children with type 1 diabetes. This is Mannkind's Afrezza, which takes the place of rapid-acting mealtime insulin. Findings indicate that inhaled insulin delivers glycemic control comparable to injected rapid-acting insulin. Inhaled insulin was also associated with less weight gain and slightly higher patient and parent preference scores. These findings add to outcomes shared from INHALE 1 late last year. Based on the findings of the inhaled insulin study, MannKind looks to seek FDA approval to expand Afrezza's indication to children. The company also aims to evaluate inhaled insulin at diagnosis and in automated insulin delivery systems in additional studies. https://www.drugdeliverybusiness.com/study-mannkind-inhaled-insulin-safe-effective-children/ XX Positive outcomes in two different studies looking at GLP 1 medications for type 1. Semaglutide – brand name Ozempic or Wegovy - reduced glucose levels and weight among patients with type 1 diabetes and obesity. 26-week, double-blind trial of 72 adults, those taking Ozempic spent More than 70% time spent in sensor glucose range (70-180 mg/dL) Less than 4% time spent in hypoglycemia (
Gretchen Zimmermann, MBA, RD, LDN, CDCES, CSOWM is a healthcare executive, registered dietitian, and thought leader in digital health innovation. With over 15 years of experience in clinical care and leadership, she is committed to transforming healthcare through cost-effective, outcome-driven, and patient-centered care models. Her expertise is nationally recognized, with publications in academic and industry journals on diabetes, digital health, and nutrition... and today she joins me to talk all things GLP-1. Let's get all the facts, shall we? Connect with Gretchen: https://www.instagram.com/gretchenzimmermann.rd/ https://www.vida.com/ --- ❤️ INSTAGRAM: www.instagram.com/KindalBoyleFitness/
Learn what age-related macular degeneration (AMD) isWhat causes AMDThe types of AMDThe update on NAION - listen to last year's podcast all about itWhy we aren't too concernedClick here to join Dr. Spencer's online clinic VineyardClick to read the JAMA AMD articleClick to read the Ophthalmology journal AMD article
Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55______________________________________________________________________If you've ever hit a weight loss stall and thought, “What am I doing wrong?”—this one's for you.In this episode, we sit down with Dr. Lindsay Ogle, a board-certified obesity medicine specialist, to unpack what's really happening when the scale stops moving, even on a GLP-1. We explore the body's built-in defenses against weight loss, the role of metabolic disease, and how hormones—especially during perimenopause and menopause—complicate the picture. Dr. Ogle breaks down the science with compassion, helping us understand why stalls happen, how to respond to them, and why it's not about failure. It's about biology.Joining us as well is a powerful voice from the community: Mrs. Clark, who began sharing her journey through a nervous breakdown in 2022 on social media and unexpectedly found herself with millions of followers. After years of struggling with her weight, she decided to try tirzepatide—and it changed everything. She opens up about the emotional toll of obesity, what it felt like to stall, and why the journey is about so much more than a number on the scale.We also dig into obesity phenotypes and why GLP-1 medications don't work the same way for everyone. For those not seeing the results they expected, Dr. Ogle walks us through combination therapies, mindset shifts, and what sustainable care really looks like.This episode is a reality check wrapped in compassion. Whether you're stalled, stuck, or just trying to make sense of what your body is doing, this conversation is your reminder: you're not alone—and it's not your fault.Community Guests Mrs ClarkTik Tok: @mrskariclarkDoctor GuestsDr. Lindsay OgleDr. Lindsay Ogle, MD is a board certified family & obesity medicine physicianwho is passionate about preventative health. Her goal is to help patients stay healthy so they may live longer and fuller lives. She recently started a telehealth clinic called Missouri Metabolic Health where she helps adults all throughout the state of Missouri treat and prevent metabolic conditions (ex: diabetes, fatty liver disease, metabolic syndrome, overweigSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
LifeBlood: We talked about sustainable pain relief, how to start feeling better without taking a pill or having surgery, what happens to our bodies when our levels of estrogen and testosterone decrease, whether or not GLP1 treatments are safe, and if it's ever too late to get healthy, with Stacey Roberts, PT, Holistic Registered Nurse, and Owner of New You Health and Wellness. Listen to learn why about feedback inhibition and the imperative role it plays in your body and overall health! You can learn more about Stacey at NewYouHealthAndWellness.com, Facebook, and LinkedIn. Thanks, as always for listening! If you got some value and enjoyed the show, please leave us a review here: https://ratethispodcast.com/lifebloodpodcast You can learn more about us at LifeBlood.Live, Twitter, LinkedIn, Instagram, YouTube and Facebook or you'd like to be a guest on the show, contact us at contact@LifeBlood.Live. Stay up to date by getting our monthly updates. Want to say “Thanks!” You can buy us a cup of coffee. https://www.buymeacoffee.com/lifeblood Copyright LifeBlood 2025.
© 2020-2025 Ivy Podcast Discovery LLC
